Acromegaly is one of those diseases that immediately caught our attention when we first heard about it in medical school. We stared at the textbook pictures of big hands and coarse faces—maybe a very ...

Acromegaly is a condition that most often happens when your pea-sized pituitary gland at the base of your brain (orange) makes too much growth hormone after your body has otherwise already stopped ...

While the most obvious signs of acromegaly are changes to your facial features and unusual growth in your hands and feet, it also has effects no one else can see. This rare disease is caused by an ...

What Is Palsonify, and Why Does It Matter? Palsonify (paltusotine) is a new once-daily oral medicine approved to treat adults with acromegaly who either didn’t get much help from surgery or cannot ...

The journal Pituitary has highlighted research led by Manel Puig, head of the Endocrine, Thyroid and Obesity Research Group at the Germans Trias i Pujol Research Institute (IGTP), which explores the ...

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

Gigantism and acromegaly are growth disorders that result from excess amounts of growth hormone in the body. The conditions are similar but have several differences. Growth hormone is one of the ...

Paltusotine is the first once-daily oral therapy approved for acromegaly, offering a non-invasive alternative to injections. PATHFNDR-1 and PATHFNDR-2 trials showed significant efficacy in IGF-1 ...

Background A 31-year-old woman presented 12 months after discontinuing the oral contraceptive pill with progressive headache to her primary-care physician. She had previously presented with irregular ...